Released May 6, 2019, after the close
10-Q filed May 6, 2019, 36 days after period end · 0001564590-19-015990
Q1 2019 · 10-Q
Revenue$109.11M$109.11M +0.4% vs Q1 2018−9.9% vs Q4 2018
Net Income$897.00K$897.00K −82.8% vs Q1 2018−89.9% vs Q4 2018
EPS Diluted$0.05$0.05 −81.5% vs Q1 2018−89.1% vs Q4 2018
Gross Profit$85,404,000+1.0%
Operating Income-$4,448,000N/M
Operating Cash Flow-$1,039,000N/M
Free Cash Flowderived-$5,682,000N/M
Margins · derived
Gross margin78.3%+0.5 pt vs Q1 2018
Operating margin-4.1%−11.3 pt vs Q1 2018
Net margin0.8%−4.0 pt vs Q1 2018
What the release said
The release
Same quarter
| Metric | Q1 2019 | Q1 2018 | Q1 2017 | Q1 2016 |
|---|---|---|---|---|
| Revenue | $109.11M | $108.71M | $102.74M | $98.68M |
| Net Income | $897.00K | $5.23M | -$2.65M | $3.84M |
| EPS Diluted | $0.05 | $0.27 | -$0.15 | $0.20 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Orthofix Medical Inc. · CIK 884624 · Engraved from SEC EDGAR